{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T09:11:21Z","timestamp":1788599481364,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antonie van Leeuwenhoek"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10482-026-02398-4","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:02:40Z","timestamp":1785736960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbial dysbiosis in a Southern Chinese cohort of patients with Parkinson's disease"],"prefix":"10.1007","volume":"119","author":[{"given":"Yi Ming","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu Zhi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald Robert","family":"Haley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9050-7267","authenticated-orcid":false,"given":"Hanadi Y.","family":"Hamadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2398_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, W\u00fcllner U (2017) Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med 9:1\u201313","journal-title":"Genome Med"},{"key":"2398_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0303-2","volume":"8","author":"CL Boulang\u00e9","year":"2016","unstructured":"Boulang\u00e9 CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E (2016) Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med 8:1\u201312","journal-title":"Genome Med"},{"issue":"1","key":"2398_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric \u03b1-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396(1):67\u201372","journal-title":"Neurosci Lett"},{"issue":"1","key":"2398_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2047-9158-4-1","volume":"4","author":"H Chen","year":"2015","unstructured":"Chen H, Zhao EJ, Zhang W, Lu Y, Liu R, Huang X, Ciesielski-Jones AJ, Justice MA, Cousins DS, Peddada S (2015) Meta-analyses on prevalence of selected Parkinson\u2019s nonmotor symptoms before and after diagnosis. Transl Neurodegener 4(1):1\u20138","journal-title":"Transl Neurodegener"},{"issue":"1","key":"2398_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep37944","volume":"6","author":"E Ciarlo","year":"2016","unstructured":"Ciarlo E, Heinonen T, Herderschee J, Fenwick C, Mombelli M, Le Roy D, Roger T (2016) Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo. Sci Rep 6(1):37944","journal-title":"Sci Rep"},{"key":"2398_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.nbd.2012.09.007","volume":"50","author":"D Devos","year":"2013","unstructured":"Devos D, Lebouvier T, Lardeux B, Biraud M, Rouaud T, Pouclet H, Coron E, des Varannes SB, Naveilhan P, Nguyen J-M (2013) Colonic inflammation in Parkinson\u2019s disease. Neurobiol Dis 50:42\u201348","journal-title":"Neurobiol Dis"},{"issue":"1","key":"2398_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-014-0311-6","volume":"14","author":"JS Escobar","year":"2014","unstructured":"Escobar JS, Klotz B, Valdes BE, Agudelo GM (2014) The gut microbiota of Colombians differs from that of Americans, Europeans and Asians. BMC Microbiol 14(1):1\u201314","journal-title":"BMC Microbiol"},{"issue":"12","key":"2398_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028032","volume":"6","author":"CB Forsyth","year":"2011","unstructured":"Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB, Keshavarzian A (2011) Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS ONE 6(12):e28032","journal-title":"PLoS ONE"},{"key":"2398_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00018-012-1028-z","volume":"70","author":"P Forsythe","year":"2013","unstructured":"Forsythe P, Kunze WA (2013) Voices from within: gut microbes and the CNS. Cell Mol Life Sci 70:55\u201369","journal-title":"Cell Mol Life Sci"},{"key":"2398_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.pharmthera.2015.11.012","volume":"158","author":"S Ghaisas","year":"2016","unstructured":"Ghaisas S, Maher J, Kanthasamy A (2016) Gut microbiome in health and disease: linking the microbiome\u2013gut\u2013brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. Pharmacol Ther 158:52\u201362","journal-title":"Pharmacol Ther"},{"issue":"9","key":"2398_CR11","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK (2004) Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations the movement disorder society task force on rating scales for Parkinson\u2019s disease. Mov Disord 19(9):1020\u20131028","journal-title":"Mov Disord"},{"issue":"5","key":"2398_CR12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill\u2010Burns","year":"2017","unstructured":"Hill\u2010Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP (2017) Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov Disord 32(5):739\u2013749","journal-title":"Mov Disord"},{"key":"2398_CR13","first-page":"403039","volume":"2011","author":"S Hisahara","year":"2011","unstructured":"Hisahara S, Shimohama S (2011) Dopamine receptors and Parkinson\u2019s disease. Int Med Chem 2011:403039","journal-title":"Int Med Chem"},{"issue":"5","key":"2398_CR14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/mds.27326","volume":"33","author":"MC Houser","year":"2018","unstructured":"Houser MC, Chang J, Factor SA, Molho ES, Zabetian CP, Hill-Burns EM, Payami H, Hertzberg VS, Tansey MG (2018) Stool immune profiles evince gastrointestinal inflammation in Parkinson\u2019s disease. Mov Disord 33(5):793\u2013804","journal-title":"Mov Disord"},{"key":"2398_CR15","unstructured":"Inc., S. IBM SPSS Statistics for Windows Version 18.0. . In SPSS Inc 2009."},{"key":"2398_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bbi.2015.03.016","volume":"48","author":"H Jiang","year":"2015","unstructured":"Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J (2015) Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48:186\u2013194","journal-title":"Brain Behav Immun"},{"issue":"9996","key":"2398_CR17","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"10","key":"2398_CR18","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian A, Green SJ, Engen PA, Voigt RM, Naqib A, Forsyth CB, Mutlu E, Shannon KM (2015) Colonic bacterial composition in Parkinson\u2019s disease. Mov Disord 30(10):1351\u20131360","journal-title":"Mov Disord"},{"issue":"4","key":"2398_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.procbio.2013.02.021","volume":"48","author":"CY Ko","year":"2013","unstructured":"Ko CY, Lin H-TV, Tsai GJ (2013) Gamma-aminobutyric acid production in black soybean milk by Lactobacillus brevis FPA 3709 and the antidepressant effect of the fermented product on a forced swimming rat model. Process Biochem 48(4):559\u2013568","journal-title":"Process Biochem"},{"issue":"1","key":"2398_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-014-0145-z","volume":"11","author":"E Kuric","year":"2014","unstructured":"Kuric E, Ruscher K (2014) Dynamics of major histocompatibility complex class II-positive cells in the postischemic brain-influence of levodopa treatment. J Neuroinflammation 11(1):1\u201312","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2398_CR21","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.copbio.2012.08.005","volume":"24","author":"JG LeBlanc","year":"2013","unstructured":"LeBlanc JG, Milani C, De Giori GS, Sesma F, Van Sinderen D, Ventura M (2013) Bacteria as vitamin suppliers to their host: a gut microbiota perspective. Curr Opin Biotechnol 24(2):160\u2013168","journal-title":"Curr Opin Biotechnol"},{"key":"2398_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li W, Wu X, Hu X, Wang T, Liang S, Duan Y, Jin F, Qin B (2017) Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci China Life Sci 60:1223\u20131233","journal-title":"Sci China Life Sci"},{"key":"2398_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/bs.irn.2017.01.002","volume":"132","author":"L Marsili","year":"2017","unstructured":"Marsili L, Marconi R, Colosimo C (2017) Treatment strategies in early Parkinson\u2019s disease. Int Rev Neurobiol 132:345\u2013360","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"2398_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/ibd.21436","volume":"17","author":"S Mondot","year":"2011","unstructured":"Mondot S, Kang S, Furet J-P, Aguirre de C\u00e1rcer D, McSweeney C, Morrison M, Marteau P, Dore J, Leclerc M (2011) Highlighting new phylogenetic specificities of Crohn\u2019s disease microbiota. Inflamm Bowel Dis 17(1):185\u2013192","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"2398_CR25","first-page":"3","volume":"4","author":"E Nagavardhan Reddy","year":"2018","unstructured":"Nagavardhan Reddy E, Govardhan Reddy SVR, Ajay Chowdary M, Tejaswi V (2018) Parkinson\u2019s disease and treatment-a review article. World J Pharm Med Res 4(3):3","journal-title":"World J Pharm Med Res"},{"issue":"5","key":"2398_CR26","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/mds.25445","volume":"28","author":"RB Postuma","year":"2013","unstructured":"Postuma RB, Gagnon JF, Pelletier A, Montplaisir J (2013) Prodromal autonomic symptoms and signs in Parkinson\u2019s disease and dementia with Lewy bodies. Mov Disord 28(5):597\u2013604","journal-title":"Mov Disord"},{"issue":"13","key":"2398_CR27","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta\u2010analysis. Mov Disord 29(13):1583\u20131590","journal-title":"Mov Disord"},{"key":"2398_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian Y, Yang X, Xu S, Wu C, Song Y, Qin N, Chen S-D, Xiao Q (2018) Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav Immun 70:194\u2013202","journal-title":"Brain Behav Immun"},{"issue":"7","key":"2398_CR29","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.cgh.2013.02.015","volume":"11","author":"M Raman","year":"2013","unstructured":"Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P (2013) Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 11(7):868-875. e863","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2398_CR30","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1016\/j.neuropharm.2012.01.026","volume":"62","author":"P Rane","year":"2012","unstructured":"Rane P, Shields J, Heffernan M, Guo Y, Akbarian S, King JA (2012) The histone deacetylase inhibitor, sodium butyrate, alleviates cognitive deficits in pre-motor stage PD. Neuropharmacology 62(7):2409\u20132412","journal-title":"Neuropharmacology"},{"issue":"6","key":"2398_CR31","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, Challis C, Schretter CE, Rocha S, Gradinaru V (2016) Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167(6):1469","journal-title":"Cell"},{"issue":"3","key":"2398_CR32","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M (2015) Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov Disord 30(3):350\u2013358","journal-title":"Mov Disord"},{"issue":"6","key":"2398_CR33","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mds.25020","volume":"27","author":"KM Shannon","year":"2012","unstructured":"Shannon KM, Keshavarzian A, Dodiya HB, Jakate S, Kordower JH (2012) Is alpha-synuclein in the colon a biomarker for premotor Parkinson\u2019s disease? Evidence from 3 cases. Mov Disord 27(6):716\u2013719","journal-title":"Mov Disord"},{"issue":"1","key":"2398_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-017-1175-y","volume":"15","author":"RK Singh","year":"2017","unstructured":"Singh RK, Chang H-W, Yan D, Lee KM, Ucmak D, Wong K, Abrouk M, Farahnik B, Nakamura M, Zhu TH (2017) Influence of diet on the gut microbiome and implications for human health. J Transl Med 15(1):1\u201317","journal-title":"J Transl Med"},{"key":"2398_CR35","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00726-010-0768-z","volume":"41","author":"SN Surwase","year":"2011","unstructured":"Surwase SN, Jadhav JP (2011) Bioconversion of L-tyrosine to L-DOPA by a novel bacterium Bacillus sp. JPJ. Amino Acids 41:495\u2013506","journal-title":"Amino Acids"},{"key":"2398_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3389\/fnagi.2017.00441","volume":"9","author":"X Yang","year":"2018","unstructured":"Yang X, Qian Y, Xu S, Song Y, Xiao Q (2018) Longitudinal analysis of fecal microbiome and pathologic processes in a rotenone induced mice model of Parkinson\u2019s disease. Front Aging Neurosci 9:441","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"2398_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.nbd.2011.08.017","volume":"45","author":"Y Yoshiyama","year":"2012","unstructured":"Yoshiyama Y, Kojima A, Itoh K, Uchiyama T, Arai K (2012) Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model. Neurobiol Dis 45(1):329\u2013336","journal-title":"Neurobiol Dis"},{"issue":"9459","key":"2398_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0140-6736(05)17909-4","volume":"365","author":"ZX Zhang","year":"2005","unstructured":"Zhang ZX, Roman GC, Hong Z, Wu CB, Qu QM, Huang JB, Zhou B, Geng ZP, Wu JX, Wen HB, Zhao H, Zahner GE (2005) Parkinson\u2019s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 365(9459):595\u2013597. https:\/\/doi.org\/10.1016\/S0140-6736(05)17909-4","journal-title":"Lancet"}],"container-title":["Antonie van Leeuwenhoek"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10482-026-02398-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10482-026-02398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T08:11:43Z","timestamp":1788595903000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10482-026-02398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2398"],"URL":"https:\/\/doi.org\/10.1007\/s10482-026-02398-4","relation":{},"ISSN":["0003-6072","1572-9699"],"issn-type":[{"value":"0003-6072","type":"print"},{"value":"1572-9699","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"26 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of the Second Affiliated Hospital of Fujian Medical University (No. 2017\u201323).","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"184"}}